Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Jornal De Pediatria
|
September 25, 2003
[Prevention of pneumococcal disease in Brazil]
Gabriel Oselka
Cadernos De Saude Publica
|
June 22, 2010
Debate on the paper by Feitosa et al
Reinaldo Ayer-de-Oliveira, Gabriel Oselka
Dementia & Neuropsychologia
|
December 8, 2017
Ethical aspects of brain death and end-of-life
Gabriel Oselka, Reinaldo Ayer de Oliveira
Journal International De Bioethique = International Journal of Bioethics
|
July 31, 2008
Clinical bioethics
Reinaldo Ayer De Oliveira, Gabriel Oselka, Cláudio Cohen, et al.
Vaccine
|
March 22, 2002
DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children
José Ignacio Santos, Amando Martin, Tirza De Leon, et al.
Lancet (London, England)
|
November 3, 2009
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
Steven Black, Juhani Eskola, Claire-Anne Siegrist, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Jornal De Pediatria
|
September 25, 2003
[Prevention of pneumococcal disease in Brazil]
Gabriel Oselka
Cadernos De Saude Publica
|
June 22, 2010
Debate on the paper by Feitosa et al
Reinaldo Ayer-de-Oliveira, Gabriel Oselka
Dementia & Neuropsychologia
|
December 8, 2017
Ethical aspects of brain death and end-of-life
Gabriel Oselka, Reinaldo Ayer de Oliveira
Journal International De Bioethique = International Journal of Bioethics
|
July 31, 2008
Clinical bioethics
Reinaldo Ayer De Oliveira, Gabriel Oselka, Cláudio Cohen, et al.
Vaccine
|
March 22, 2002
DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children
José Ignacio Santos, Amando Martin, Tirza De Leon, et al.
Lancet (London, England)
|
November 3, 2009
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
Steven Black, Juhani Eskola, Claire-Anne Siegrist, et al.
Page
of 1